Lassila R - Search Results

1

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial.

Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg PG, Storey RF, Wojdyla D, Wallentin L; PLATO study group. Husted S, et al. Among authors: lassila r. Eur Heart J. 2014 Jun 14;35(23):1541-50. doi: 10.1093/eurheartj/ehu075. Epub 2014 Mar 28. Eur Heart J. 2014. PMID: 24682844 Free PMC article. Clinical Trial.

2

Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation.

Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V. Badimon L, et al. Among authors: lassila r. Blood. 1991 Jul 15;78(2):423-34. Blood. 1991. PMID: 2070078 Free article.

3

Inflammation in atheroma: implications for plaque rupture and platelet-collagen interaction.

Lassila R. Lassila R. Eur Heart J. 1993 Dec;14 Suppl K:94-7. Eur Heart J. 1993. PMID: 8131797 Review.

4

Atherogenesis and inflammation.

Jang IK, Lassila R, Fuster V. Jang IK, et al. Among authors: lassila r. Eur Heart J. 1993 Dec;14 Suppl K:2-6. Eur Heart J. 1993. PMID: 8131783 Review.

5

Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenoses on thrombus growth.

Lassila R, Badimon JJ, Vallabhajosula S, Badimon L. Lassila R, et al. Arteriosclerosis. 1990 Mar-Apr;10(2):306-15. doi: 10.1161/01.atv.10.2.306. Arteriosclerosis. 1990. PMID: 2317165

6

A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall--studies in a porcine model.

Badimon L, Martínez-González J, Royo T, Lassila R, Badimon JJ. Badimon L, et al. Among authors: lassila r. Thromb Haemost. 1999 Dec;82(6):1736-42. Thromb Haemost. 1999. PMID: 10613663

7

Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project.

Fischer K, Lassila R, Peyvandi F, Calizzani G, Gatt A, Lambert T, Windyga J, Iorio A, Gilman E, Makris M; EUHASS participants. Fischer K, et al. Among authors: lassila r. Thromb Haemost. 2015 May;113(5):968-75. doi: 10.1160/TH14-10-0826. Epub 2015 Jan 8. Thromb Haemost. 2015. PMID: 25567324 Free article.

8

Pseudoaneurysm in association with a knee endoprothesis operation in an inhibitor-positive haemophilia A patient - treatment with local thrombin.

Saarela MS, Tiitola M, Lappalainen K, Vikatmaa P, Pinomäki A, Alberty A, Lassila R. Saarela MS, et al. Among authors: lassila r. Haemophilia. 2010 Jul 1;16(4):686-8. doi: 10.1111/j.1365-2516.2010.02205.x. Epub 2010 Feb 23. Haemophilia. 2010. PMID: 20201962 No abstract available.

9

Use of antithrombotic therapy in patients with hemophilia: A selected synopsis of the EHA-ISTH-EAHAD-ESO Clinical Practice Guidance document.

Escobar M, Lassila R, Bekdache C, Owaidah T, Sholzberg M. Escobar M, et al. Among authors: lassila r. J Thromb Haemost. 2024 Nov 19:S1538-7836(24)00685-8. doi: 10.1016/j.jtha.2024.10.033. Online ahead of print. J Thromb Haemost. 2024. PMID: 39571935 Free article.

10

A case of acquired factor XI deficiency and severe bleeding tendency associated with Streptococcus pyogenes cellulitis.

El Beayni N, Lassila R, Lehtinen AE, Sivula M, Szanto T. El Beayni N, et al. Among authors: lassila r. Br J Haematol. 2024 Nov 13. doi: 10.1111/bjh.19908. Online ahead of print. Br J Haematol. 2024. PMID: 39538405 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters